Literature DB >> 17952507

Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.

Huseyin Yildirim1, Muzaffer Metintas, Güntülü Ak, Sinan Erginel, Fusun Alatas, Emel Kurt, Selma Metintas, Irfan Ucgun.   

Abstract

Chemical pleurodesis using various sclerosing agents is accepted palliative therapy for patients with recurrent, symptomatic, malignant pleural effusions (MPE). However, the utility of various clinical and biochemical parameters in predicting pleurodesis outcome is still controversial. The objective of this study was to investigate the relationship between pleural fluid adenosine deaminase (Pf-ADA) levels and talc pleurodesis outcomes, and to compare Pf-ADA levels to various other biochemical variables with respect to predicting talc pleurodesis outcome in patients with MPE. In this prospective trial, 60 consecutive patients with MPE were enrolled; 35 had malignant mesothelioma (MM) and 25 had metastatic pleural carcinoma (MPC). A complete response was achieved in 49 of 60 MPE patients (81.7%). The Pf-ADA, pH, and albumin levels in patients with successful pleurodesis were significantly higher than in those with unsuccessful pleurodesis (p values < 0.001, 0.036, 0.027, respectively). ROC curve analysis revealed that optimal differentiation between successful and unsuccessful pleurodesis could be achieved with cutoff points of 17.5 U/L for Pf-ADA (area under the curve = 0.873; sensitivity = 77.6%; specificity = 90.9%); >2.5 g/dl for albumin (area under the curve = 0.715; sensitivity = 85.4%; specificity = 54.5%); and >7.26 for pleural fluid pH (area under the curve = 0.703; sensitivity = 83.7%; specificity = 54.5%). In analysis of the subgroup, Pf-ADA were found to be a good marker for discrimination between successful and unsuccessful pleurodesis in patients with MM (p < 0.001) but not in the MPC group (p = 0.068). These results indicate that Pf-ADA levels could be considered predictors of the outcome of pleurodesis, especially in patient with MM. Furthermore, the present study also demonstrated that Pf-ADA level is a superior test to predict the outcome of pleurodesis compared to pleural fluid pH and albumin level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952507     DOI: 10.1007/s00408-007-9042-x

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

1.  Adenosine deaminase in the diagnosis of tuberculous pleural effusion.

Authors:  Y P Kataria; I Khurshid
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

2.  Adenosine deaminase in the diagnosis of tuberculous pleural effusion: is it really an ideal test? A word of caution.

Authors:  Rafael Laniado-Laborín
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

3.  The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis.

Authors:  K Psathakis; E Calderón-Osuna; B Romero-Romero; J Martin-Juan; A Romero-Falcón; F Rodriguez-Panadero
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

4.  Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis.

Authors:  E Marchi; F S Vargas; M M Acencio; L Antonangelo; E H Genofre; L R Teixeira
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

Review 5.  Lymphocytes in pleural disease.

Authors:  Nicola Dalbeth; Y C Gary Lee
Journal:  Curr Opin Pulm Med       Date:  2005-07       Impact factor: 3.155

6.  T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.

Authors:  Masakazu Okamoto; Yoshinori Hasegawa; Toru Hara; Naozumi Hashimoto; Kazuyoshi Imaizumi; Kaoru Shimokata; Tsutomu Kawabe
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

7.  Role of biochemical tests in the diagnosis of exudative pleural effusions.

Authors:  Dilek Ernam; Figen Atalay; H Canan Hasanoglu; Ozgül Kaplan
Journal:  Clin Biochem       Date:  2005-01       Impact factor: 3.281

8.  Tuberculous pleural effusions.

Authors:  Luis Valdés; Antonio Pose; Esther San José; José Manuel Martínez Vázquez
Journal:  Eur J Intern Med       Date:  2003-03       Impact factor: 4.487

9.  Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy.

Authors:  Mo-Lung Chen; Wai-Cho Yu; Ching-Wan Lam; Kam-Ming Au; Fuk-Yip Kong; Albert Yan-Wo Chan
Journal:  Clin Chim Acta       Date:  2004-03       Impact factor: 3.786

10.  Is albumin gradient or fluid to serum albumin ratio better than the pleural fluid lactate dehydroginase in the diagnostic of separation of pleural effusion?

Authors:  Jose Joseph; Padmanabhan Badrinath; Gurnam S Basran; Steven A Sahn
Journal:  BMC Pulm Med       Date:  2002-03-22       Impact factor: 3.317

View more
  5 in total

1.  Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.

Authors:  Ricardo Mingarini Terra; Leila Antonangelo; Alessandro Wasum Mariani; Ricardo Lopes Moraes de Oliveira; Lisete Ribeiro Teixeira; Paulo Manuel Pego-Fernandes
Journal:  Lung       Date:  2016-06-14       Impact factor: 2.584

2.  Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions.

Authors:  Ourania S Kotsiou; Panagiota Tzortzi; Rafailia A A Beta; Athanasios Kyritsis; Konstantinos I Gourgoulianis
Journal:  J Clin Lab Anal       Date:  2017-12-07       Impact factor: 2.352

3.  Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?

Authors:  Bojan Zarić; Vesna Kuruc; Aleksandar Milovančev; Marica Markovic; Tatjana Šarčev; Vukašin Čanak; Slobodan Pavlović
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

4.  The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage.

Authors:  Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim; Giulio Maurizi; Camilla Poggi; Rocco Barile; Francesco Cassiano; Erino A Rendina
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

5.  Pleural effusion adenosine deaminase: a candidate biomarker to discriminate between Gram-negative and Gram-positive bacterial infections of the pleural space.

Authors:  Ruolin Li; Junli Wang; Xinfeng Wang; Maoshui Wang
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.